Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT UBC Medical Indonesia TbkISX:LABS -4.60%2 Net-Net Working Capital is Rp0.00 as of . 20. GuruFocus rates ISX:LABS with a GF Score™ of 2/100. The stock has 2 warning signs investors should review. Among 412 Medical Devices & Instruments companies, PT UBC Medical Indonesia Tbk ranks worse than 242718.2% on this metric.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.
The industry rank for PT UBC Medical Indonesia Tbk's Net-Net Working Capital or its related term are showing as below:
ISX:LABS's Price-to-Net-Net-Working-Capital is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 6.735 * Ranked among companies with meaningful Price-to-Net-Net-Working-Capital only.
PT UBC Medical Indonesia Tbk (ISX:LABS) Net-Net Working Capital Explanation
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.
PT UBC Medical Indonesia Tbk Net-Net Working Capital Related Terms
PT UBC Medical Indonesia Tbk Net-Net Working Capital Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT UBC Medical Indonesia Tbk Net-Net Working Capital Chart
PT UBC Medical Indonesia Tbk Annual Data
Trend
Net-Net Working Capital
PT UBC Medical Indonesia Tbk Quarterly Data
Net-Net Working Capital
ISX:LABS vs ABT, SYK, MDT: Net-Net Working Capital Comparison
For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT UBC Medical Indonesia Tbk Price-to-Net-Net-Working-Capital vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's Price-to-Net-Net-Working-Capital distribution charts can be found below:
* The bar in red indicates where PT UBC Medical Indonesia Tbk's Price-to-Net-Net-Working-Capital falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.
In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
This is a conservative way of estimating the company's value.
What does a Net-Net Working Capital of Rp0.00 mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a Net-Net Working Capital of Rp0.00 as of . 20. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on PT UBC Medical Indonesia Tbk According to the industry distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 412 companies in the Medical Devices & Instruments industry.
Is PT UBC Medical Indonesia Tbk's Net-Net Working Capital too high?
PT UBC Medical Indonesia Tbk's current Net-Net Working Capital is Rp0.00. Based on the distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 412 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, PT UBC Medical Indonesia Tbk has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does PT UBC Medical Indonesia Tbk's Net-Net Working Capital compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT UBC Medical Indonesia Tbk ranks #999999 out of 412 companies for Net-Net Working Capital. This places PT UBC Medical Indonesia Tbk in the lower half of its industry. The industry median Net-Net Working Capital is 6.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net-Net Working Capital for a Medical Devices & Instruments company?
The median Net-Net Working Capital among Medical Devices & Instruments companies is 6.74, based on 412 companies in the industry. Companies in the top quartile (top 25%) have a Net-Net Working Capital significantly above this median, while those in the bottom quartile fall well below. However, Net-Net Working Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net-Net Working Capital mean?
A high Net-Net Working Capital can signal that a stock is expensive relative to its fundamentals. Ben Graham defined net-net working capital as the per-share sum of cash, 75% of receivables and 50% of inventory less total liabilities. View historical data on PT UBC Medical Indonesia Tbk For the Medical Devices & Instruments industry, the median Net-Net Working Capital is 6.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT UBC Medical Indonesia Tbk's current Net-Net Working Capital is Rp0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current Net-Net Working Capital of Rp0.00. The current Net-Net Working Capital is Rp0.00. PT UBC Medical Indonesia Tbk's overall GF Score™ is 2/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net-Net Working Capital calculated?
Net-Net Working Capital is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current Net-Net Working Capital is Rp0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.
2GF Score
Get the complete analysis for ISX:LABS
Net-Net Working Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:LABS has been successfully added to your 
